STK11 and squamous cell carcinoma: We examined the dose-dependent anticancer activity of metformin in the absence and presence of exogenously supplemented thymidine plus hypoxanthine in LKB1-expressing human squamous carcinoma A431 cells [69] and HeLa cervical carcinoma cells bearing a biallelic deletion of LKB1 [70].